Qureshi

H1841 Y. Ahmad, T. Begum, I. H. Qureshi, Atta-ur-Rahman, K. Zaman, X. 

M Qureshi et al., Recent progress in ion-exchange studies on insoluble salts of polybasic metals Separation Sci. 1972, 7, 615... 

Cameron, G. G., Qureshi, Y. IUPAC Intern. Symp. on Macromolecules, Florence, Italy, Preprints, Vol. 2, 193 (1980)... 

Acikalin T, Wait S, Garimella S, Raman A (2004) Experimental investigation of the thermal performance of piezoelectric fans. Heat Transfer Eng 25 4-14 Adams TM, Abdel-Khalik SI, Jeter SM, Qureshi ZH (1998) An experimental investigation of single-phase forced convection in micro-channels. Int J Heat Mass Transfer 41 851-857 Adams TM, Dowling ME, Abdel-Khalik SI, Jeter SM (1999) Applicability of traditional turbulent single phase forced convection correlations to non-circular micro-channels. Int J Heat Mass Transfer 42 4411 415... 

Adams TM, Abdel-Khalik SI, Jeter SM, Qureshi ZH (1998) An experimental investigation of single-phase forced convection in micro-channels. Int J Heat Mass Transfer 41 851-857... 

Qureshi Al, Siddiqui AM, Kim SH, Hanel RA, Xavier AR, Kirmani JF, Suri ME, Boulos AS, Hopkins LN. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004 25 322-328. 

Qureshi Al, Harris-Lane P, Kirmani IF, Janjua N, Divani AA, Mohammad YM, Suarez Jl, Montgomery MO. Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke an open-label, dose-ranging, phase I study. Neurosurgery 2006 59 789-796 [discussion 796-787]. 

Mahon BR, Nesbit GM, Barnwell SL, Clark W, Marotta TR, Weill A, Teal PA, Qureshi Al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. Am J Neuroradiol 2003 24 534-538. 

Qureshi et al." evaluated the timing of deterioration in patients with massive MCA strokes in a multicenter retrospective chart review. They found that 68% of patients manifested clinical deterioration by 48 hours, and nearly another 20% did so by 72 hours. Thus, the first 3-5 days appears to be the most crucial time for detecting patients at high risk for deterioration, although there was a small minority of patients who had deterioration at greater than 5 days from symptom onset. Early impairment in consciousness was also found to be predictive of mortality in one cohort of patients within a randomized chnical trial." One postmortem study of 192 patients found features in 45 patients that they postulate led to mahgnant ... 

Qureshi AI, Suarez JI, Yahia AM, Mohammad Y, Uzun G, Suri MF, Zaidat OO, Ayata C, Ali Z, Wityk RJ. Timing of neurological deterioration in massive middle cerebral artery infarction a multicenter review. Crit Care Med 2003 31(l) 272-277. 

Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Schnitzer MS, Mirski M, Hanley DF, Ulatowski JA. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998 26(6) 1118-1122. 

Qureshi A, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000 28(9) 3301-3313. 

Inhibition of HMGCoA reductase and hypolipidemic effect (Qureshi and Qureshi 1992 Tomeo and Geller 1995 Parker et ah, 1993). 

Inhibition of phospholipase A2, thromboxane B4 and enhancement of prostacyclin production (Raederstorff et al., 2002 Qureshi and Qureshi, 1992). 

---